1 ���, �c�, �r�ent� �linical ���i�tant, �e�artment o� �ral an� �a�illo�acial �urger�, �c�ool o� �enti�tr�, �ni�er�it� o� �t�-���, �c�, �r�ent� �linical ���i�tant, �e�artment o� �ral an� �a�illo�acial �urger�, �c�ool o� �enti�tr�, �ni�er�it� o� �t�-en�, �t�en�, Greece 2 ���, �r�ent� ���i�tant Pro�e��or, �e�artment o� �ral Pat�olog�, �c�ool o� �enti�tr�,�ni�er�it� o� �t�en�, �t�en�, Greece 3 ���, �r�ent� ���i�tant Pro�e��or, �e�artment o� �ral an� �a�illo�acial �urger�, �c�ool o� �enti�tr�,�ni�er�it� o� �t�en�, �t�en�, Greece 4 ���, �r�ent� ���i�tant Pro�e��or, �e�artment o� �ral �iagno�i� an� Ra�iolog�, �c�ool o� �enti�tr�,�ni�er�it� o� �t�en�, �t�en�, Greece 5 ��, �r��e�� ���i�tant Pro�e��or, Laborator� o� Foren�ic �e�icine an� To�icolog�, �e�ical �c�ool, �ni�er�it� o� �t�en�, �t�en�, Greece Abstract �bjecti�e�: t�e e��re��ion o� t�e o�teocla�togenic c�tokine� TNF-α, IL-6 an� IL-1β were immuno�i�toc�emi-call� e�aluate� in �eri��eral (PG�G) an� central (�G�G) giant cell granuloma� o� t�e jaw� in or�er to �etermine �i��erence� between t�e�e two le�ion� an� between t�e two �i�tinct tumor cell �o�ulation� (multinucleate� giant cell�, �G�� an� �tromal ��in�le-��a�e� cell�)� �tu�� �e�ign: Para�fin-embe��e� ti��ue �ection� �rom 40 PG�G an� 40 �G�G were immuno�i�toc�emicall� �taine� u�ing antibo�ie� again�t TNF-α, IL-6 an� IL-1β� T�e �ercentage o� �o�iti�el� �taine� cell� an� t�e �taining inten�it� were a��e��e� to �ro�i�e a combine� immunoreacti�it� �core �alue� Re�ult�: TNF-α, IL-6 an� IL-1β were e��re��e� in all le�ion�� T�e �G�G com�are� to t�e PG�G ��owe� �ig-nificantl� increa�e� e��re��ion o� TNF-α an� IL-6 an� �ecrea�e� e��re��ion o� IL-1β b� t�e ��in�le-��a�e� cell� an� increa�e� e��re��ion o� IL-1β b� t�e �G��� T�e �G�� �emon�trate� in com�ari�on to t�e �tromal ��in�le-��a�e� cell� �ignificantl� increa�e� e��re��ion o� all t�ree c�tokine� in bot� PG�G an� �G�G� �onclu�ion�: T�e �roinflammator� c�tokine� TNF-α, IL-6 an� IL-1β �eem to be in�ol�e� in t�e growt� �roce�� o� PG�G an� �G�G o� t�e jaw�� � �o��ible alteration in t�e ��nt�e�i� or/an� acti�it� o� t�e�e c�tokine� b� t�e �tromal ��in�le cell� in t�e �G�G� ma� en�ance o�teol��i� t�roug� t�e �timulation o� o�teocla�t �rogenitor cell�, gi�en t�e �act t�at t�e intrao��eou� le�ion� cau�e bone re�or�tion�
Introduction
T�e central giant cell granuloma (�G�G) o� t�e jaw� re�re�ent� a non-neo�la�tic an� localize� benign but �ometime� aggre��i�e o�teol�tic �roli�eration (1)� Τ�i� entit� mo�t commonl� occur� in t�e man�ible a� an e�-�an�ile ra�iolucenc�, ��ow� �ariable clinical be�a�iour an� a �ub�et o� le�ion� ma� e��ibit locall� aggre��i�e growt� �attern wit� ra�i� tumour enlargement a��oci-ate� wit� teet� �i��lacement, root re�or�tion or bone cortical �er�oration (2-4)� T�e origin o� �G�G i� uncertain� Local trauma, inflammation, intrao��eou� blee�-ing an� genetic abnormalitie� �a�e been regar�e� a� �o��ible cau�e�, but a unique e��lanation �a� not gaine� a wi�e acce�tance (5)� T�e �eri��eral giant cell granuloma (PG�G) i� an e�-trao��eou� giant cell le�ion� In t�e oral ca�it� t�i� le�ion �re�ent� a� a �e��ile or �e�unculate� �ur�le-brown e�o���tic ma��, locate� on t�e gingi�al or t�e al�eolar muco�a (4)� In �ome ca�e� o� PG�G a �lig�t �u�erfi-cial (cu��ing) ero�ion o� t�e a�jacent bone can be �een ra�iologicall� (6)� T�e e�act aetiolog� o� PG�G� �till remain� unclear� �e�elo�mental or/an� inflammator� reaction� in t�e �erio�ontal ligament or t�e �erio�teum �a�e been �ro�o�e� to be in�ol�e� (4,6)� Local irritation �actor� �uc� a� �oor �ental re�toration�, un�table �ental �ro�t�e�i�, �ental e�traction�, �laque an� calculu� accumulation an� �oo� retention �eem to �la� a �ignificant role in t�e �e�elo�ment o� a PG�G (7)� T�e two le�ion� (�G�G an� PG�G) �emon�trate i�en-tical �i�to�at�ologic �eature� (4)� T�e� are bot� c�ar-acterize� b� numerou� multinucleate� giant cell� in a fibrobla�tic �a�cularize� �troma wit� o�oi� to ��in�le-��a�e� cell� w�ic� are t�oug�t to com�o�e a �eterog-enou� �o�ulation o� macro��age an� fibrobla�tic-like cell� (8)� T�e origin o� t�e multinucleate� giant cell� (�G��) �a� been a matter o� con�i�erable intere�t� T�e�e cell� are con�i�ere� to be �orme� �rom t�e �u�ion o� monoc�te/ macro��age �recur�or� �i��erentiate� into o�teocla�t� un�er t�e influence o� c�tokine� (8-10)� T�e mononuclear cell com�onent o� t�e G�G� con�i�t� o� a �o�ula-tion o� macro��age-like cell�, w�ic� a��ear� to inclu�e a �ub�et o� o�teocla�t �recur�or�, an� a �roli�erating ��in�le-��a�e� �tromal cell �o�ulation w�ic� �a� t�e ca�acit� to �i��erentiate along fibrobla�t/o�teobla�t line�� T�e fibrobla�t/o�teobla�t-like cell� in G�G� o� t�e jaw e��re��ing t�e rece�tor acti�ator o� NF-κB ligan� -R�NKL, w�ic� i� a �rimar� me�iator o� o�teocla�t �i�-�erentiation, acti�ation, an� �ur�i�al, are re��on�ible �or in�ucing t�e �ormation o� o�teocla�t-like �G�� �rom monoc�te�/macro��age� �oun� in t�e�e le�ion� (11,12)� �an� o�teotro�ic �ormone� an� c�tokine� �a�e �i-rect or in�irect �timulator� an� antagoni�tic e��ect� on t�e �e�elo�ment o� t�e o�teocla�t�� TNF-α i� a multi�unctional c�tokine relea�e� b� acti�ate� monoc�te�, macro��age� an� T l�m��oc�te� an� contribute� to immune re��on�e�, regulating growt�, �i��erentiation, an� �urt�er �ro�uction o� ot�er c�tokine�, inflammator� me�iator� an� enz�me�� TNF-α i� a �otent bone re�or�tion in�ucer t�at �timulate� o�teocla�t �i��eren-tiation an� acti�ation� T�e �roinflammator� c�tokine� IL-6 an� IL-1β, �ro�uct� o� �tromal cell� an� monoc�te�, �timulate in a��ociation wit� TNF-α o�teocla�t �i��erentiation an� acti�ation in a ��nergi�tic �a��ion� T�e�e c�tokine� not onl� regulate o�teocla�togene�i� b� �tromal cell�, but al�o act �irectl� on o�teocla�t� an� t�eir �recur�or� (11,13,14)� T�e role o� TNF-α, IL-6 an� IL-1β in t�e �at�ogene�i� o� o�teol�tic le�ion� an� �i�ea�e� wit� �at�ologic bone re�or�tion �a� been �ro�e� (11)� T�e�e o�teocla�togenic c�tokine� �a�e been in�e�tigate� b� u�ing �ariou� met�-o�� in giant cell tumor� (G�T�) o� long bone� in �e�eral �tu�ie� in �i�o an� in �itro (8,15-17)� T�e e��re��ion o� TNF-α �a� al�o been �tu�ie� in �atient� wit� giant cell le�ion� o� t�e jaw� (18,19)� In t�e �re�ent �tu��, t�e TNF-α, IL-6 an� IL-1β e��re�-�ion were immuno�i�toc�emicall� e�aluate� in �eri��-eral an� central giant cell granuloma� o� t�e jaw�, in or�er to �etermine �o��ible �i��erence� between t�e�e two entitie� an� between multinucleate� giant cell� an� �tromal ��in�le-��a�e� cell�� To our knowle�ge, t�ere are no �tu�ie� in t�e Engli�� literature concerning t�e in �itu com�arati�e immuno�i�toc�emical e��re��ion o� t�i� tria� o� c�tokine� between t�e PG�G an� �G�G o� t�e jaw��
Material and methods

Study group
In t�i� �tu��, file� o� �atient� wit� a �efinite �iagno�i� o� PG�G an� �G�G �rom t�e �e�artment o� �ral Pat�ol-og� an� �e�icine, Facult� o� �enti�tr�, �ni�er�it� o� �t�en� were re�i�e�, t�e �iagno�i� in eac� ca�e �a�ing been ma�e on t�e ba�i� o� clinical, ra�iologic an� �i�to-logic fin�ing�� Formalin-fi�e� an� �ara�fin-embe��e� -ti��ue �am�le� o� all t�e ca�e� were retrie�e�� �ll ��eci-men� were obtaine� �rom �urgical e�ci�ion o� t�e le�ion� an� �a� been fi�e� in 10% bu��ere� �ormalin� ���e��-ment o� �emato��lin an� eo�in-�taine� �ection� o� all ca�e� toget�er wit� e�aluation o� clinical an� ra�iologic �ata too were �one �o a� t�e �iagno�i� o� t�e le�ion� to be confirme�� Fort� (n=40) ca�e� o� PG�G� an� �ort� (n=40) ca�e� o� �G�G� were �electe�� T�e �election criteria inclu�e� t�e �re�ence in t�e �atient�' recor�� o� �etaile� clinical in�ormation (age, gen�er, anatomic location, clinical �eature�, �ign� an� ��m�tom� at �re�-entation) a� well a� ra�iogra��� (intraoral ra�iogra��ie� �or t�e ca�e� o� PG�G�, �anoramic ra�iogra��ie� an�/ or �T �can� �or t�e ca�e� o� �G�G�)� In all t�e ca�e� o� �G�G�, laborator� te�t� �alue� �or �erum calcium an� ��o���oru� concentration�, alkaline ��o���ata�e acti�-e58 it� an� �arat��roi� �ormone le�el were al�o a�ailable� In all �atient� t�e�e �arameter� were wit�in t�e re�er-ence range�, e�clu�ing t�e occurrence o� ot�er �i�ea�e� w�ic� coul� com�romi�e t�e final �iagno�i� o� �G�G� �o�t �atient� were �emale� (55% o� ca�e� wit� PG�G an� 70% o� ca�e� wit� �G�G)� T�e mean age o� �a-tient� wit� PG�G an� �G�G wa� 49�2 �ear� an� 45 �ear� re��ecti�el�� Bot� PG�G an� �G�G ��owe� a �re�ilection �or t�e anterior region o� t�e man�ible (75% o� PG�G an� 67% o� �G�G)� PG�G� mainl� a�-�eare� a� re� �e�unculate� le�ion� wit� �moot� �ur-�ace an� rubber� con�i�tenc� (59%), w�ile in 34% o� t�e ca�e� a �u�erficial, cu�-��a�e� ra�iolucenc� wa� �een ra�iogra��icall�� T�e mo�t common clinical fin�ing o� �G�G� wa� bon� e��an�ion o� t�e jaw (75%), w�ile in more aggre��i�e le�ion� cortical �er�oration, toot� �i�-�lacement an�, rarel�, �ain an� �are�t�e�ia were al�o ob�er�e�� In ra�iogra��ic e�amination, a unilocular or multilocular ra�iolucenc� wa� ob�er�e�� Immunohistochemistry T�e immuno�i�toc�emical �taining wa� �er�orme� on 3-5μm t�ick �ara�fin-embe��e� ti��ue �ection�� �ec-tion� were �e�ara�finize� in ��lene, ���rate� t�roug� gra�e� alco�ol an� wa��e� wit� Tri�-bu��ere� �aline (TB�) �or 10 min an� �i�tille� water �or anot�er 10 min� En�ogenou� �ero�i�a�e acti�it� wa� blocke� wit� 3% �/� H 2 O 2 in water �or 5-min� �ntigen retrie�al wa� �er-�orme� �or all antibo�ie� b� �lacement o� t�e �ection� in citrate bu��er an� �eating in microwa�e o�en �or 15 min� �ection� were �e�aratel� incubate� o�ernig�t wit� t�e �rimar� antibo�ie� �or TNF-α (mou�e, monoclonal, H�2010, H�cult Biotec�, �ilution 1:10), IL-6 (goat, �ol-�clonal, �c1265, �anta �ruz Biotec�, �ilution 1:150) an� IL-1β (mou�e, monoclonal, �c52012, �anta �ruz Biotec�, �ilution 1:400) an� t�en incubate� in t�e biotinconjugate� �econ�ar� antibo�� �or 10 min� T�e �tan�-ar� �tre�ta�i�in-biotin-�ero�i�a�e com�le� met�o� wa� �er�orme� to bin� t�e �rimar� antibo�� wit� t�e u�e o� a L��B ���tem �ni�er�al Kit (�ako) �or 10 min, ��B �olution wa� u�e� a� c�romogen �or 5 min an� all �ection� were counter�taine� wit� �a�er΄� �aema-to��lin �or 1 min an� mounte�� Po�iti�e ti��ue control� inclu�e� �uman inflame� �kin �or TNF-α, gliobla�toma �or IL-6 an� �iloni�al c��t �or IL-1β� For negati�e control� �li�e� t�e antibo�� wa� omitte�� In eac� �ection, �our �ig�-�ower fiel�� were ran�oml� �electe�, wit� a 40X magnification, an� t�e �ercentage o� �o�iti�el� �taine� cell� (PP) o� t�e �G�� an� �tro-mal ��in�le-��a�e� cell� wa� a��e��e� in eac� fiel� b� two ob�er�er� a�: 0 (<10% �taine� cell�), 1 (≥10%), 2 (≥25%), 3 (≥50%), an� 4 (≥75%)� �taining inten�it� (�I) wa� gra�e� a�: 0=no e��re��ion, 1=weak, 2=mo�erate an� 3=�trong� T�e immuno�i�toc�emical e��re��ion �or eac� c�tokine wa� e�aluate� b� u�ing t�e �coring met�-o� ImmunoReacti�it� �core «IR�» (20,21)� �ccor�ing to t�i�, t�e �core o� t�e �ercentage o� �taine� cell� (PP) �or eac� fiel� wa� multi�lie� b� t�e �core o� t�e �taining inten�it� (�I) to �ro�i�e a combine� immunoreacti�it� �core �alue (IR�) (IR�: PP×�I)� T�e mean o� t�e �our fiel�� wa� t�e IR� �core �or t�e �am�le� Statistical analysis �tati�tical anal��i� wa� �er�orme� b� �P�� 13�0 �tati�ti-cal �ackage� Becau�e t�e �ata were con�orme� to abnormal �i�tribution�, t�e non-�arametric �ann-W�itne� wa� u�e�� T�e �i��erence� were con�i�ere� a� �tati�ti-call� �ignificant at le�el �=0�05�
Results
�ll tumor� ��owe� �imilar �i�tological �eature� e��ibit-ing a great number o� �G�� �urroun�e� b� cell �o�ula-tion� wit� o�al to ��in�le cell mor��olog� in a loo�e fibrillar connecti�e ti��ue �troma wit� man� �mall bloo� �e��el�� Hemo�i�erin (11 ca�e� in �G�G an� 7 ca�e� (Figure 1 �,B,�)� T�e giant cell� �emon�trate� in com�ari�on to t�e �tromal ��in�le-��a�e� cell� �ignificantl� increa�e� e��re��ion o� all t�ree c�tokine� in bot� PG�G an� �G�G� � �ariable e��re��ion �or t�e e�amine� c�-tokine� wa� ob�er�e� �rom t�e �tromal ��in�le-��a�e� cell� in �eri��eral an� central le�ion� (Table 1) � ��e-cificall�, in 95% o� t�e central an� in 82�5% o� t�e �e-ri��eral G�G�, t�e ��in�le cell� ��owe� e��re��ion �or TNF-α (Fig. 1� )� IL-6 wa� e��re��e� b� t�e �tromal ��in�le-��a�e� cell� in all ca�e� o� t�e �G�G� (Fig.  1B) an� in 90% o� PG�G�, w�ile IL-1β wa� e��re��e� b� t�e�e cell� in 85% o� t�e �eri��eral an� 45% o� t�e central le�ion�� T�ere wa� no �tati�ticall� �ignificant �i��erence between PG�G an� �G�G con�i�ering t�e e��re��ion o� TNF-α an� IL-6 b� �G��, in contra�t to t�e �tromal ��in�le-��a�e� cell�, w�ic� in �G�G� ��owe� a �ig-nificantl� increa�e� e��re��ion o� t�e�e two c�tokine� (Table 1 )� T�e com�ari�on between �G�G an� PG�G con�i�ering t�e e��re��ion o� IL-1β re�eale� t�at t�e �G�G ��owe� �ignificantl� increa�e� IL-1β e��re��ion b� �G�� an� �ecrea�e� IL-1β e��re��ion b� �tromal ��in�le-��a�e� cell� (Fig. 1C) .
Discussion
T�e o�teocla�togenic c�tokine� TNF-α, IL-6 an� IL-1β �a�e been in�e�tigate� in giant cell tumor� (G�T�) o� long bone�� W�et�er t�e G�G� o� t�e jaw� an� t�e G�T� o� long bone� are reall� a �ingle �at�ologic �roc-e�� i� an unan�were� que�tion� T�e� are bot� c�aracter-ize� b� t�e �re�ence o� �G�� , alt�oug� G�T� ma� e��ibit �ig�er mean number o� giant cell� �er mea�-urement fiel�, �ig�er number o� nuclei �er giant cell, greater �ractional area an� relati�e �ize in�e� an� �ig�er necro�i� (22,23)� �G�G�, �e��ite t�eir reacti�e nature, ��ow �ig�er �roli�erati�e acti�it� (24)� T�e� are muc� le�� �e�tructi�e an� ten� to in�ol�e a �ounger age grou� (23)� G�T� ��ow neo�la�tic c�aracteri�tic� (24)� T�e� are u�uall� �ain�ul an� �a�t growing (5), c�aracterize� b� an un�re�ictable biological be�a�ior, local aggre�-�i�ene�� an� �ig� recurrence rate� (25)� T�e �i�tinction between t�e G�G� an� t�e G�T� ma� be contro�er�ial, but t�eir �i�to�at�ological an� immuno�i�toc�emi-cal �imilaritie� �eem to reflect a �imilar �at�ogene�i�, con�i�ere� to re�re�ent a ��ectrum o� t�e �ame �i�ea�e �roce�� (22,23)� To our knowle�ge t�i� i� t�e fir�t �tu�� regar�ing �imul-taneou�l� �etermination o� t�e�e t�ree �roinflammato-r� c�tokine� b� bot� �G�� an� �tromal ��in�le-��a�e� cell� in PG�G� an� �G�G� o� t�e jaw�� In a �re�iou� �tu��, �maral et al� (18) in�e�tigate� t�e e��re��ion o� TNF-α in �eri��eral an� central giant cell le�ion� o� t�e jaw� an� �oun� �ecrea�e� tran�cri�tion o� TNF-α gene� in all t�e ca�e� �tu�ie� com�are� to �ealt�� control �am- IL-6 immuno�i�toc�emical e��re��ion in �G�G (Χ60)� �trong �taining inten�it� o� �G�� an� mo�erate �taining inten�it� in �tromal ��in�le-��a�e� cell�, (�) IL-1β immuno�i�toc�emical e��re��ion in �G�G (Χ120)� �trong �taining inten�it� o� �G�� �or IL-1β an� no immunoreacti�it� in �tromal ��in�le-��a�e� cell�� �le�� In a��ition, �e �ouza et al� (19) e�aluate� TNF-α e��re��ion b� circulating l�m��oc�te� an� monoc�te� in �atient� wit� central giant cell le�ion� o� t�e jaw� an� �oun� increa�e� e��re��ion o� t�i� c�tokine b� ��4(+) T cell� an� �ecrea�e� �requenc� o� TNF-α+ cell� in ��68+ circulating monoc�te�� T�e aut�or� �ro�o�e t�at a� t�e re�ult� o� t�e �tu�� �emon�trate� an increa�e� e��re��ion o� IL-10 b� monoc�te� an� �ince IL-10 in�ibit� IL-1, IL-6 an� TNF-α �ro�uction b� acti�ate� macro��age� (24), t�e �ig�er e��re��ion o� IL-10 coul� �o��ibl� e��lain t�e ob�er�e� �ecrea�e� �requenc� o� TNF-α+ cell�� �ccor�ing to t�i� �tu��, it i� intere�ting t�at alt�oug� central giant cell le�ion� are locali�e� in t�e jaw�, t�e� ma� cau�e �ignificant ���temic �unctional alteration� in circulating leukoc�te�� W�et�er t�e central giant cell le�ion� ma� cau�e �eri��eral leukoc�te acti�ation or t�i� acti�ation ma� be cau�e� b� ot�er �ac-tor� an� �timulate� t�e �ormation o� central giant cell le�ion� remain� to be eluci�ate� (19)� T�e re�ult� o� t�e �re�ent �tu�� are in agreement wit� t�o�e �oun� in G�T�, w�ic� ��ow �ariable e��re��ion o� t�e TNF-α, IL-6 an� IL-1 b� multinucleate� giant cell� an� �tromal ��in�le-��a�e� cell� (8, 15-17)� T�e TNF-α, IL-6 an� IL-1β e��re��ion in �eri��eral an� central G�G� o� t�e jaw in�icate� t�at t�e�e c�tokine� are im�licate� in t�e growt� �roce�� o� bot� e�trao�-�eou� an� intrao��eou� giant cell le�ion� �u��orting t�e �re�iou�l� �tate� o�inion t�at �eri��eral an� central G�G� ��are �imilar growt� �otential (26,27)� T�e�e o�-teocla�togenic c�tokine� com�ri�e a tria� o� �actor� t�at interact an� ma� �la� a critical role in �G�� �ormation regulating t�e bone re�or�tion (28), �ugge�ting a �o�-�ible ��nergi�tic role in t�e �e�elo�ment o� G�G�� Τ�e �G�� e��ibit �unctional an� ��enot��ic c�aracteri�-tic� o� o�teocla�t� inclu�ing tartrate-re�i�tant aci� ��o�-��ata�e, amino-�e�ti�a�e, V-�TPa�e, �� II, �at�e�-�in K, ��P-9 an� ��68, �itronectin an� calcitonin rece�tor� T�e abo�e �imilaritie� between �G�� an� o�teocla�t� are in�icati�e �or a common �i�togene�i� (12,21,29)� Recentl�, t�e �tu�� o� �maral et al� (18) in PG�G� an� �G�G� ��owe� increa�e� tran�cri�tion o� t�e nuclear �actor o� acti�ate� T cell� (NF�Tcl), w�ic� i� a ma�ter o� tran�cri�tion in terminal �i��erentiation o� o�teocla�t�� T�e�e aut�or� �ro�o�e� t�at t�e �e�elo�-ment o� giant cell le�ion� o� t�e jaw� i� �o��ibl� me�i-ate� b� o�ere��re��ion o� NF�T in t�e nucleu� o� t�e �GG�� In t�e �re�ent �tu��, t�e �G�� immuno�tain-ing �or TNF-α, IL-6 an� IL-1β ma� �o��ibl� be relate� to o�teocla�t �i��erentiation� T�e ��in�le-��a�e� cell� in t�e mononuclear cell com�onent o� t�e PG�G an� �G�G �a�e been �ro�e� to re�re�ent t�e "�roli�erating com�artment" con�i�ere� re��on�ible �or t�e biologic acti�it� o� t�e�e tumor�� T�e�e me�enc��mal in origin cell� re�embling immature o�teobla�t� relea�e a wi�e range o� �actor� (rece�-tor acti�ator o� NF-κB ligan� -R�NKL, interleukine�, inter�eron gamma -IFN-γ, macro��age-colon� �timu-lating �actor -���F, granuloc�te-macro��age colon� �timulating �actor -G���F) t�at recruit monoc�te�/ o�teocla�t �recur�or� an� �romote t�eir �i��erentiation into �unctional o�teocla�t� (8,21, 26-28)� In t�e �re�ent �tu��, t�e com�ari�on between t�e �eri��eral an� central G�G� re�eale� t�at in t�e �G�G t�ere wa� a �ta-ti�ticall� �ignificant increa�e� e��re��ion o� TNF-α an� IL-6 b� t�e ��in�le cell�, but not b� t�e �G��� TNF-α i� re��on�ible �or �timulating o�teocla�tic bone re�or�-tion in �itro a� well a� in �i�o (11,14)� IL-6 i� known to �timulate me�enc��mal �rogenitor �i��erentiation towar� t�e o�teobla�tic lineage an� i� al�o a �otent antia�o�totic agent on o�teobla�tic cell�� T�e main �ource� o� IL-6 in bone are o�teobla�tic cell�, �tromal cell� an� not o�teocla�tic cell�, but t�e acti�it� o� IL-6 on bone i� it� e��ect on o�teocla�togene�i� (11)� In contra�t to t�e increa�e� e��re��ion o� TNF-α an� IL-6 b� t�e ��in�le cell� in our �tu��, t�e �G�G ��owe� �ignificantl� increa�e� IL-1β e��re��ion b� t�e �G�� an� �ecrea�e� IL-1β e��re��ion b� t�e �tromal ��in�le-��a�e� cell�� Gamberi et al� (15) b� u�ing immuno�i�-toc�emi�tr� an� real-time quantitati�e P�R tec�nique� �oun� increa�e� e��re��ion o� IL-6 in G�T� a��ociate� wit� �ig�er biological aggre��i�ene��, but wit�out an� �ignificant �i��erence� between t�e two cell �o�ula-tion�� Increa�e� e��re��ion o� TNF-α, IL-1 an� IL-6 mRN� b� �tromal cell� �a� been ob�er�e� in G�T� b� �tkin� et al (16)� �n t�e ot�er �an�, immunoreacti�it� �or IL-1β, IL-6 an� TNF-α al�o confirme� b� in �itu ��-bri�ization wa� mainl� ob�er�e� in giant cell�, w�erea� �tromal cell� ��owe� �cattere� �taining in G�T� (17)� Regezi (26) ��eculate� t�at t�e �ub�et o� �G�G� t�at ��ow a locall� aggre��i�e be�a�iour ma� �e�elo� �rom a reacti�e le�ion t�roug� an e�igenetic e�ent occurring in ��in�le-��a�e� me�enc��mal cell� o� bone re�ulting in e�ca�e �rom cell c�cle control� an� in e��re��ion o� �rotein� ca�able o� monoc�te recruitment an� �i��eren-tiation into �G��� ��teocla�tic �i��erentiation i� controlle� b� com�le� interaction� between �PG, R�NK an� R�NKL� �PG an� R�NKL are ��nt�e�ize� b� �tromal cell�/o�teobla�t�, w�ile R�NK i� localize� at t�e cell �ur�ace o� mature o�teocla�t� an� o�teocla�tic �recur�or�� �PG in�ibit� o�teol��i� an� block� R�N-KL/R�NK interaction� TNF-α, IL-6 an� IL-1 ma� al�o �la� a role in t�e o�teocla�tic �i��erentiation an� increa�e �ro�uction o� bot� R�NKL an� �PG� T�e�e c�tokine� al�o act �irectl� on o�teocla�t� an� t�eir �re-cur�or� an� a��itionall� t�e� �a�e an im�ortant e��ect in �timulating R�NKL �ro�uction b� o�teobla�tic cell� an� in acting ��nergi�ticall� wit� R�NKL (11)� T�e re�ult� o� t�e �re�ent �tu�� ��owe� t�at t�e �tromal ��in�le-��a�e� cell� in �G�G� �emon�trate� increa�e� TNF-α, IL-6 an� �ecrea�e� IL-1β immuno�i�toc�emi-e61 cal e��re��ion com�are� to t�e PG�G�� �lt�oug�, immuno�i�toc�emical o�ere��re��ion ma� not nece��aril� reflect o�er�ro�uction o� t�e�e o�teocla�togenic molecule� b� t�e ��in�le cell� in �G�G�, a �o��ible alteration in t�e ��nt�e�i� or/an� acti�it� o� t�e�e regulator� c�tokine� wit�in t�e bone microen�ironment ma� en�ance o�teol��i� t�roug� t�e �timulation o� o�teocla�t �rogenitor cell�, gi�en t�e �act t�at intrao��eou� le�ion� cau�e bone re�or�tion� T�e �G�� in PG�G ma� occa�ionall� ��ow bone re�or�ti�e ca�acit� a�jacent to t�e le�ion� T�e cellular com�o�ition in PG�G �a� been ��owe� to be �imilar wit� t�at in giant cell le�ion� o� �i��erent �ite� an� �G�� e��re�� t�e �ame o�teol�tic �rotea�e� an� o�teocla�t-acti�ating c�tokine� in�ol�e� in bone metaboli�m (30)� In PG�G, t�e TNF-α, IL-6 an� IL-1β interrelation� ma� control t�e cellular acti�i-tie� o� t�e �i��erent cell �o�ulation� (multinuclear cell�, monoc�te�/macro��age�, ��in�le fibrobla�t�/o�teob-la�t�) contributing �o��ibl� mainl� in t�e mec�ani�m� o� tumor growt�, an� occa�ionall� o� o�teol��i�� Frie�ric� et al� (30) anal�ze� t�e e��re��ion o� �rotea�e� rele�ant �or o�teol��i� in giant cell le�ion� an� ��owe� t�at �e-��ite o� t�e �trong cat�e��in K e��re��ion b� t�e �G�� in PG�G�, t�ere wa� no ra�iological e�i�ence �or jaw o�teol��i� a�jacent to t�e e�amine� le�ion�� �ccor�ing to t�e�e aut�or�, t�e ca�acit� o� cat�e��in K to �egra�e bone �eem� to be relate� not to t�e �ig� amount� o� t�i� �rotein in giant cell�, but to t�e to�ogra��� o� t�e le�ion in relation to t�e a�jacent bone, �ince o�teocla�t� more �i�tantl� locate� to bone ma� contain an inacti�e �orm (�rocat�e��in K) an� not t�e mature, acti�e cat�e��in K� In conclu�ion, t�e �roinflammator� c�tokine� TNF-α, IL-6 an� IL-1β �eem to be in�ol�e� in t�e growt� �roc-e�� o� �eri��eral an� central G�G� o� t�e jaw�� Furt�er �tu�ie� are nece��ar� to clari�� t�e �unctional role o� t�e�e c�tokine� in t�e �e�elo�ment o� PG�G� an� �G�G� an� to �etermine w�et�er control o�er t�e�e �rotein� ma� �ro�i�e anot�er �trateg� �or �uture me�i-cal treatment o� t�e�e tumor�� 
